Lawsuit claims Pfizer massaged Neurontin studies

LONDON (Reuters) - Pfizer Inc tried to suppress medical studies that did not support the use of its epilepsy drug Neurontin, internal Pfizer documents submitted in a U.S. lawsuit against the company showed. The documents suggest that Pfizer's marketers influenced Neurontin's scientific record to boost sales at least until 2003 by delaying the publication or altering the conclusions of studies that had found no evidence the drug worked for various conditions besides epilepsy. Pfizer, the world's biggest drugmaker, denied the charges. "Pfizer is committed to the communication of medically or scientifically significant results of all studies, regardless of outcome," a company spokesman said in a statement. The case is the latest in a string of allegations against the pharmaceutical industry suggesting it has controlled the flow... [read full story]